The table below shows agilon health, inc.'s cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
Line item
FY 2025
FY 2024
FY 2023
FY 2022
FY 2021
FY 2020
Operating cash flow
-$105.76M
-$57.78M
-$156.20M
-$130.81M
-$148.16M
-$53.20M
Capital expenditure
$13.24M
$13.25M
$15.83M
$15.43M
$6.56M
$1.77M
Investing cash flow
$88.61M
$139.89M
-$44.02M
-$444.39M
-$90.51M
$22.07M
Dividends paid
-
-
-
-
-
AGL operating cash flow (10-K history)
agilon health, inc. reported operating cash flow of -$105.76M for fiscal year 2025. That is down 83.1% from -$57.78M in fiscal 2024. Over the 7 fiscal years shown, operating cash flow declined from -$103.86M (FY 2019) to -$105.76M. Figures come from the company's audited annual reports as filed with the SEC.
